US Stock MarketDetailed Quotes

GILD Gilead Sciences

Watchlist
  • 76.770
  • +0.280+0.37%
Close Aug 2 16:00 ET
  • 76.760
  • -0.010-0.01%
Post 20:01 ET
95.64BMarket Cap213.25P/E (TTM)

Gilead Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gilead Sciences Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 8, 2024

Revenue(YoY)

6.74B

+2.06%
EPS(YoY)

1.13

+36.18%
Analyst Rating

Buy

Aug 3, 2024

Gilead Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.984B--
Aug 8, 20242024/Q2-- / 6.735B--
Apr 25, 20242024/Q16.686B / 6.349B--
Feb 6, 20242023/Q47.115B / 7.104B--
Nov 7, 20232023/Q37.051B / 6.800B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.984B--
Aug 8, 20242024/Q2-- / 6.735B--
Apr 25, 20242024/Q16.686B / 6.349B--
Feb 6, 20242023/Q47.115B / 7.104B--
Nov 7, 20232023/Q37.051B / 6.800B--

Unlock Free Earnings Estimates

Gilead Sciences Earnings Reports

  • Gilead Sciences | 10-Q: Quarterly report

    May 8 17:02 ET

  • Gilead Sciences | 10-K: Annual report

    Feb 23 22:39 ET

  • Gilead Sciences: Q3 2023 Earnings Report

    Nov 7, 2023 17:18 ET

  • Gilead Sciences | 10-Q: Q2 2023 Earnings Report

    Aug 4, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 3, 2024

    Buy

    • Buy

      55.56%

    • Hold

      44.44%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday+0.82%
    Cancer Research
    Cancer Research
    Intraday+0.46%